Sell Dell!: Against...
Health Care: Drugs
Novogen Ltd. (NVGN: NASDAQ)
$2.34 0.00 | 0.00%
05/24/12 - 02:03 PM ET
13.15K / 3.40K
Vol / Avg. Vol:2.34 / 2.34
Open / Prev. Close:2.34 - 2.39
Today's Range:2.00 - 8.25
52 Wk Range:0.00%
Performance YTD:TheStreet Rating:
Portfolios with NVGN
- Portfolio NameUser Type
- UserSUPRATRADE HOT STOCKS (BUY ...
- UserSUPRATRADE HOT STOCKS (BUY ...
- User©SUPRATRADE HOT STOCKS (...
- Userscjs4r speculative
- UserJim G Portfolio 1
- UserDavidrs Portfolio 1
- UserInsider Purchases and Buyba...
- UserBarron's Insider Purchases ...
- UserTRM Portfolio 1
- UserBarron's Insider Purchases ...
Latest NVGN Headlines from TheStreet
- Tiny Biotechs Dancing in the Bull Pen 05.20.09 | 12:05 pm
- Monday's Health Winners & Losers 09.18.06 | 03:09 pm
- Friday's Health Winners & Losers 08.25.06 | 03:08 pm
- Health Stocks in Motion 07.06.04 | 05:07 pm
Press Releases for NVGN
- As Released On 30 December, 2011: Novogen Modifies ADR Program And Makes Further Investment Into Marshall Edwards - PR Newswire 01.04.12 | 05:01 pm
- Glycotex, Inc. Awarded Cash Grant Under The U.S. Government Qualifying Therapeutic Discovery Program - PR Newswire 11.24.10 | 08:11 am
- Marshall Edwards Reaches Agreement In Principle To Acquire Intellectual Property Portfolio From Novogen - PR Newswire 09.08.10 | 08:09 am
- Marshall Edwards To Host Conference Call On September 8, 2010 - PR Newswire 08.31.10 | 09:08 am
- Marshall Edwards Appoints Oncologist Christine White To Board Of Directors - PR Newswire 08.10.10 | 07:08 am
Partner Headlines for NVGN
- On January 3rd, Novogen to Change ADR Conversion Ratio, Similar to a 5:1 Reverse Stock Split - Benzinga 12.29.11 | 01:12 pm
- Top Buy and Sell Ideas Based on Wednesday's Biggest Gainers - Seeking Alpha 07.28.11 | 09:07 am
